BML-210

• Background:

  A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10 µM (HeLa nuclear extract) . Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.

• Conjugation:

  Unconjugated

• Buffer:

  Tan solid (MP = 168-170°C)

• Storage Conditions:

  -20°C